NCT01806311View on ClinicalTrials.gov

Safety and Pharmacokinetics Study of amlodipine10mg and candesartan32mg

PHASE1CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

December 31, 2012

Primary Completion Date

August 31, 2013

Study Completion Date

August 31, 2013

Conditions
Hypertension
Interventions
DRUG

Candesartan32mg

DRUG

Amlodipine10mg

Trial Locations (1)

301-721

Chungnam national university hospital,clinical trial center, Daejeon

Sponsors
All Listed Sponsors
lead

HanAll BioPharma Co., Ltd.

INDUSTRY